Topical delgocitinib shows promise for chronic hand eczema, pivotal trial showsMarch 27, 2023Atopic Dermatitis
New data forecast more oral PDE4 inhibitors for psoriasisMarch 27, 2023PsoriasisAtopic DermatitisPsoriatic Arthritis
JAK inhibitor safety warnings drawn from rheumatologic data may be misleading in dermatologyMarch 19, 2023Atopic DermatitisPsoriasisMedical Dermatology
Study finds quality of topical steroid withdrawal videos on YouTube subparMarch 17, 2023Atopic DermatitisMedical Dermatology
Lebrikizumab monotherapy for AD found safe, effective during inductionMarch 15, 2023Atopic DermatitisPediatrics
How to help pediatricians apply peanut allergy guidelinesMarch 6, 2023PediatricsUrticariaAtopic Dermatitis
AD outcomes improved with lebrikizumab and topical steroidsJanuary 17, 2023Atopic DermatitisPediatrics
Cochrane Review bolsters case that emollients don’t prevent ADDecember 22, 2022Atopic DermatitisPediatrics
Dupilumab significantly improves markers of AD severity in pediatric patientsDecember 15, 2022PediatricsAtopic Dermatitis
Parental atopic dermatitis, asthma linked to risk of AD in offspringDecember 9, 2022Atopic DermatitisPediatrics
